Michael Holtzman

Principal investigator.

Biotech

Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.

2018First federal award

$600KFederal grants as PI2 awards

0Patents grantedNone matched

0PapersOpenAlex

Career record

Federal awards and patents by year

20182019

AwardsPatents

Federal awards as principal investigator

2 awards · $600K

Date	Agency	Award	Amount	Company
Aug 7, 2019	NIH	STTR Phase I A New Small-Molecule Kinase Inhibitor for Airway Disease	$300K	NuPeak Therapeutics, Inc. with UNIVERSITY OF WASHINGTON
Sep 5, 2018	NIH	STTR Phase I A New Small-Molecule Kinase Inhibitor for Breast Cancer	$300K	NuPeak Therapeutics, Inc. with WASHINGTON UNIVERSITY

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#2,191

Awards as PI#1,252

Patents#273

From filings, awards and patents

Companies

NuPeak Therapeutics, Inc.Linked by awards · Biotech

Research partners on awards

Research institutions

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.